EOLS
Price
$13.99
Change
-$0.63 (-4.31%)
Updated
Feb 21 closing price
Capitalization
846.82M
9 days until earnings call
RDHL
Price
$4.76
Change
-$0.14 (-2.86%)
Updated
Feb 21 closing price
Capitalization
15.74M
18 days until earnings call
Ad is loading...

EOLS vs RDHL

Header iconEOLS vs RDHL Comparison
Open Charts EOLS vs RDHLBanner chart's image
Evolus
Price$13.99
Change-$0.63 (-4.31%)
Volume$585.97K
Capitalization846.82M
Redhill Biopharma
Price$4.76
Change-$0.14 (-2.86%)
Volume$3.71K
Capitalization15.74M
EOLS vs RDHL Comparison Chart
Loading...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EOLS vs. RDHL commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOLS is a Hold and RDHL is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (EOLS: $13.99 vs. RDHL: $4.76)
Brand notoriety: EOLS and RDHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EOLS: 71% vs. RDHL: 31%
Market capitalization -- EOLS: $846.82M vs. RDHL: $15.74M
EOLS [@Pharmaceuticals: Other] is valued at $846.82M. RDHL’s [@Pharmaceuticals: Other] market capitalization is $15.74M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EOLS’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • EOLS’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, EOLS is a better buy in the long-term than RDHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EOLS’s TA Score shows that 6 TA indicator(s) are bullish while RDHL’s TA Score has 3 bullish TA indicator(s).

  • EOLS’s TA Score: 6 bullish, 4 bearish.
  • RDHL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EOLS is a better buy in the short-term than RDHL.

Price Growth

EOLS (@Pharmaceuticals: Other) experienced а -5.09% price change this week, while RDHL (@Pharmaceuticals: Other) price change was -8.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Reported Earning Dates

EOLS is expected to report earnings on May 13, 2025.

RDHL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EOLS($847M) has a higher market cap than RDHL($15.7M). EOLS YTD gains are higher at: 26.721 vs. RDHL (-23.349). RDHL has higher annual earnings (EBITDA): 52.8M vs. EOLS (-41.81M). EOLS has more cash in the bank: 62.8M vs. RDHL (7.01M). RDHL has less debt than EOLS: RDHL (2.28M) vs EOLS (127M). EOLS has higher revenues than RDHL: EOLS (202M) vs RDHL (35.7M).
EOLSRDHLEOLS / RDHL
Capitalization847M15.7M5,395%
EBITDA-41.81M52.8M-79%
Gain YTD26.721-23.349-114%
P/E RatioN/AN/A-
Revenue202M35.7M566%
Total Cash62.8M7.01M895%
Total Debt127M2.28M5,560%
FUNDAMENTALS RATINGS
EOLS vs RDHL: Fundamental Ratings
EOLS
RDHL
OUTLOOK RATING
1..100
3051
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5494
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDHL's Valuation (92) in the Biotechnology industry is in the same range as EOLS (94) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (64) in the Pharmaceuticals Major industry is somewhat better than the same rating for RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew somewhat faster than RDHL’s over the last 12 months.

EOLS's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

EOLS's Price Growth Rating (54) in the Pharmaceuticals Major industry is somewhat better than the same rating for RDHL (94) in the Biotechnology industry. This means that EOLS’s stock grew somewhat faster than RDHL’s over the last 12 months.

RDHL's P/E Growth Rating (81) in the Biotechnology industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EOLSRDHL
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRZZX5.470.10
+1.86%
Leuthold Grizzly Short Fund
BGLYX13.69-0.03
-0.22%
Brookfield Global Listed InfrastructureI
DDFIX18.64-0.23
-1.22%
Invesco Diversified Dividend R5
JCVIX24.78-0.34
-1.35%
JHancock Classic Value I
PSIJX8.15-0.25
-2.98%
Principal SmallCap Growth I J

EOLS and

Correlation & Price change

A.I.dvisor tells us that EOLS and RDHL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EOLS and RDHL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
-4.31%
RDHL - EOLS
29%
Poorly correlated
-2.86%
ACET - EOLS
26%
Poorly correlated
-2.66%
EVOK - EOLS
26%
Poorly correlated
-3.53%
SNDL - EOLS
25%
Poorly correlated
+0.57%
AMPH - EOLS
23%
Poorly correlated
-0.06%
More

RDHL and

Correlation & Price change

A.I.dvisor tells us that RDHL and EOLS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDHL and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
-2.86%
EOLS - RDHL
29%
Poorly correlated
-4.31%
ACET - RDHL
27%
Poorly correlated
-2.66%
PTPI - RDHL
26%
Poorly correlated
-5.59%
CYTH - RDHL
24%
Poorly correlated
-4.03%
SNOA - RDHL
23%
Poorly correlated
-1.03%
More